OPT-Sciences Corporation
OPT-Sciences Corporation Fundamental Analysis
OPT-Sciences Corporation (OPST) shows weak financial fundamentals with a PE ratio of 15.84, profit margin of 15.75%, and ROE of 8.18%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze OPST's fundamental strength across five key dimensions:
Efficiency Score
WeakOPST struggles to generate sufficient returns from assets.
Valuation Score
ExcellentOPST trades at attractive valuation levels.
Growth Score
ModerateOPST shows steady but slowing expansion.
Financial Health Score
ExcellentOPST maintains a strong and stable balance sheet.
Profitability Score
ModerateOPST maintains healthy but balanced margins.
Key Financial Metrics
Is OPST Expensive or Cheap?
P/E Ratio
OPST trades at 15.84 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, OPST's PEG of 0.16 indicates potential undervaluation.
Price to Book
The market values OPT-Sciences Corporation at 1.24 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 15.07 times EBITDA. This signals the market has high growth expectations.
How Well Does OPST Make Money?
Net Profit Margin
For every $100 in sales, OPT-Sciences Corporation keeps $15.75 as profit after all expenses.
Operating Margin
Core operations generate 10.56 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $8.18 in profit for every $100 of shareholder equity.
ROA
OPT-Sciences Corporation generates $7.57 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
OPT-Sciences Corporation produces operating cash flow of $853.63K, showing steady but balanced cash generation.
Free Cash Flow
OPT-Sciences Corporation generates strong free cash flow of $749.38K, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.97 in free cash annually.
FCF Yield
OPST converts 4.25% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
15.84
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.16
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.24
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.49
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
25.19
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How OPST Stacks Against Its Sector Peers
| Metric | OPST Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 15.84 | 26.49 | Better (Cheaper) |
| ROE | 8.18% | 1307.00% | Weak |
| Net Margin | 15.75% | -5131.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.81 | Strong (Low Leverage) |
| Current Ratio | 25.19 | 10.48 | Strong Liquidity |
| ROA | 7.57% | -1549792.00% (disorted) | Weak |
OPST outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews OPT-Sciences Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
EPS CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
FCF CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure